Showing results (81-90 of 104) with videos related to

Sort By:
Pageof 11
Bioconjugate Chemistry|July 1, 1997
Bivalent hapten-bearing peptides designed for iodine-131 pretargeted radioimmunotherapyE Janevik-Ivanovska, E Gautherot, M Hillairet de Boisferon, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1993
Radioimmunodetection of medullary thyroid cancer using a bispecific anti-CEA/anti-indium-DTPA antibody and an indium-111-labeled DTPA dimerP Peltier, C Curtet, J F Chatal, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1993
Bispecific monoclonal antibody-mediated targeting of an indium-111-labeled DTPA dimer to primary colorectal tumors: pharmacokinetics, biodistribution, scintigraphy and immune responseJ M Le Doussal, A Chetanneau, A Gruaz-Guyon, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1985
Methotrexate-vindesine association in leukemia: pharmacokinetic studyN Tubiana, N Lena, J Barbet, et al.
Nuclear Medicine Communications|December 1, 1994
Pretargetted imaging of colorectal cancer recurrences using an 111In-labelled bivalent hapten and a bispecific antibody conjugateA Chetanneau, J Barbet, P Peltier, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|March 21, 2007
Radiolabeling and targeting of lipidic nanocapsules for applications in radioimmunotherapyE Jestin, M Mougin-Degraef, A Faivre-Chauvet, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 24, 2001
Two-step targeting of xenografted colon carcinoma using a bispecific antibody and 188Re-labeled bivalent hapten: biodistribution and dosimetry studiesJ F Gestin, A Loussouarn, M Bardiès, et al.
Pageof 11